PlainRecalls
FDA Drug Moderate Class II Ongoing

Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10

Reported: January 24, 2024 Initiated: January 11, 2024 #D-0232-2024

Product Description

Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10

Reason for Recall

Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Details

Recalling Firm
Par Sterile Products LLC
Units Affected
1721 cartons
Distribution
Nationwide USA
Location
Rochester, MI

Frequently Asked Questions

What product was recalled?
Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10. Recalled by Par Sterile Products LLC. Units affected: 1721 cartons.
Why was this product recalled?
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 24, 2024. Severity: Moderate. Recall number: D-0232-2024.